Close Menu

Astronauts have successfully used CRISPR-Cas9 gene editing technology in space for the first time, says the Genes in Space initiative. The technology was used on the International Space Station (ISS) to induce targeted breaks in the yeast genome. The purpose of the experiment is to track the molecular changes the yeast makes as it repairs the breaks, in order to see if it can provide insights on how cells repair their DNA in space.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US National Institutes of Health's All of Us project awarded $4.6 million to the company Color to develop a genetic counseling resource for the program.

The Times of India reports on a pilot study that used genomic testing to determine whether patients had drug-resistant tuberculosis.

New guidelines say that more women may benefit from genetic testing for hereditary breast or ovarian cancer, according to the Los Angeles Times.

In Cell this week: small proteins identified among human microbiome, role for tumor microbes in pancreatic cancer survival, and more.